首页STAR • NSE
add
Strides Pharma Science Ltd
昨日收盘价
₹577.20
当日价格范围
₹531.20 - ₹590.00
年度波幅
₹324.70 - ₹804.00
市值
519.71亿 INR
平均交易量
64.60万
市盈率
22.42
股息率
0.44%
主要交易所
NSE
相关资讯
财务信息
损益表
收入
净收入
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 120.11亿 | 20.18% |
经营支出 | 51.79亿 | 6.06% |
净收入 | 9.32亿 | 170.98% |
净利润率 | 7.76 | 159.06% |
每股收益 | — | — |
息税折旧摊销前利润 | 23.48亿 | 53.62% |
有效税率 | 18.46% | — |
资产负债表
总资产
负债总额
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 24.70亿 | -24.31% |
总资产 | 598.96亿 | -5.49% |
负债总额 | 377.46亿 | -13.11% |
权益总额 | 221.50亿 | — |
发行在外的股份 | 9194.48万 | — |
市净率 | 2.34 | — |
资产回报率 | — | — |
资本回报率 | 10.17% | — |
现金流
现金净变动
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | 9.32亿 | 170.98% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
成立时间
1990
员工数量
3,065